These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9454327)

  • 1. Chemokine mutation slows progression.
    Balter M
    Science; 1998 Jan; 279(5349):327. PubMed ID: 9454327
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC).
    Winkler C; Modi W; Smith MW; Nelson GW; Wu X; Carrington M; Dean M; Honjo T; Tashiro K; Yabe D; Buchbinder S; Vittinghoff E; Goedert JJ; O'Brien TR; Jacobson LP; Detels R; Donfield S; Willoughby A; Gomperts E; Vlahov D; Phair J; O'Brien SJ
    Science; 1998 Jan; 279(5349):389-93. PubMed ID: 9430590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine control of HIV-1 infection.
    Mellado M; Rodríguez-Frade JM; Vila-Coro AJ; de Ana AM; Martínez-A C
    Nature; 1999 Aug; 400(6746):723-4. PubMed ID: 10466720
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective effect of an SDF-1 variant in HIV disease: abstract and commentary.
    Michael NL
    JAMA; 1998 Apr; 279(14):1140. PubMed ID: 9546575
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.
    Soriano A; Martínez C; García F; Plana M; Palou E; Lejeune M; Aróstegui JI; De Lazzari E; Rodriguez C; Barrasa A; Lorenzo JI; Alcamí J; del Romero J; Miró JM; Gatell JM; Gallart T
    J Infect Dis; 2002 Oct; 186(7):922-31. PubMed ID: 12232832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS research. Receptor mutations help slow disease progression.
    Cohen J
    Science; 1996 Sep; 273(5283):1797-8. PubMed ID: 8815542
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemokine genes--beating the odds.
    Stewart G
    Nat Med; 1998 Mar; 4(3):275-7. PubMed ID: 9500597
    [No Abstract]   [Full Text] [Related]  

  • 8. A chemokine trap for HIV co-receptors.
    Lusso P
    Nat Med; 1997 Oct; 3(10):1074-5. PubMed ID: 9334710
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
    Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
    J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summaries for patients. Genes and HIV progression.
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759637
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing.
    Unutmaz D; Littman DR
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1615-8. PubMed ID: 9050826
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.
    O'Brien SJ; Moore JP
    Immunol Rev; 2000 Oct; 177():99-111. PubMed ID: 11138790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarity of chemokines charge and the V3 domain of HIV-1 env protein.
    Berkhout B; Das AT
    Emerg Infect Dis; 1998; 4(2):335-6. PubMed ID: 9621211
    [No Abstract]   [Full Text] [Related]  

  • 14. CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research.
    Anzala AO; Ball TB; Rostron T; O'Brien SJ; Plummer FA; Rowland-Jones SL
    Lancet; 1998 May; 351(9116):1632-3. PubMed ID: 9620723
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results.
    Hendel H; Cho YY; Gauthier N; Rappaport J; Schächter F; Zagury JF
    Biomed Pharmacother; 1996; 50(10):480-7. PubMed ID: 9091061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.
    Nabatov AA; Pollakis G; Linnemann T; Kliphius A; Chalaby MI; Paxton WA
    J Virol; 2004 Jan; 78(1):524-30. PubMed ID: 14671134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines and chemokine receptors in susceptibility to HIV-1 infection and progression to AIDS.
    Chatterjee A; Rathore A; Vidyant S; Kakkar K; Dhole TN
    Dis Markers; 2012; 32(3):143-51. PubMed ID: 22377730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor.
    Lee S; Tiffany HL; King L; Murphy PM; Golding H; Zaitseva MB
    J Virol; 2000 Aug; 74(15):6946-52. PubMed ID: 10888633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.
    Faure S; Meyer L; Costagliola D; Vaneensberghe C; Genin E; Autran B; Delfraissy JF; McDermott DH; Murphy PM; Debré P; Théodorou I; Combadière C
    Science; 2000 Mar; 287(5461):2274-7. PubMed ID: 10731151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal-derived factor-1 chemokine gene variant is associated with the delay of HIV-1 disease progression in two longitudinal cohorts.
    Dezzutti CS; Guenthner PC; Green TA; Cohen OJ; Spira TJ; Lal RB
    AIDS; 2000 May; 14(7):894-6. PubMed ID: 10839599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.